» Articles » PMID: 32232085

Review of the Role of the Nervous System in Glucose Homoeostasis and Future Perspectives Towards the Management of Diabetes

Overview
Journal Bioelectron Med
Date 2020 Apr 2
PMID 32232085
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is a disease caused by a breakdown in the glucose metabolic process resulting in abnormal blood glucose fluctuations. Traditionally, control has involved external insulin injection in response to elevated blood glucose to substitute the role of the beta cells in the pancreas which would otherwise perform this function in a healthy individual. The central nervous system (CNS), however, also plays a vital role in glucose homoeostasis through the control of pancreatic secretion and insulin sensitivity which could potentially be used as a pathway for enhancing glucose control. In this review, we present an overview of the brain regions, peripheral nerves and molecular mechanisms by which the CNS regulates glucose metabolism and the potential benefits of modulating them for diabetes management. Development of technologies to interface to the nervous system will soon become a reality through bioelectronic medicine and we present the emerging opportunities for the treatment of type 1 and type 2 diabetes.

Citing Articles

Establishment, Prediction, and Validation of a Nomogram for Cognitive Impairment in Elderly Patients With Diabetes.

Wu S, Pan D, Wang H, Guo J, Zhang F, Ning Y J Diabetes Res. 2024; 2024:5583707.

PMID: 39188897 PMC: 11347027. DOI: 10.1155/2024/5583707.


New Diabetic Treatment by Alleviation of Autonomic Nervous System Dysfunction Measured as Periosteal Pressure Sensitivity at Sternum Improves Empowerment, Treatment Satisfaction, and Self-Reported Health of People with Type 2 Diabetes: A Randomized....

Hecquet S, Ballegaard S, Eldrup E, Hansen C, Hansen T, Harboe G Diabetes Metab Syndr Obes. 2024; 17:2519-2531.

PMID: 38910915 PMC: 11193981. DOI: 10.2147/DMSO.S455216.


In Type 2 Diabetes Mellitus, normalization of hemoglobin A1c accompanies reduced sensitivity to pressure at the sternum.

Faber J, Ballegaard S, Orsted N, Eldrup E, Karpatschof B, Gyntelberg F Front Neurosci. 2023; 17:1067098.

PMID: 37389368 PMC: 10303981. DOI: 10.3389/fnins.2023.1067098.


Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance.

Al-Sayyar A, Hammad M, Williams M, Al-Onaizi M, Abubaker J, Alzaid F Metabolites. 2023; 13(3).

PMID: 36984824 PMC: 10058084. DOI: 10.3390/metabo13030384.


The role of exercise and hypoxia on glucose transport and regulation.

Soo J, Raman A, Lawler N, Goods P, Deldicque L, Girard O Eur J Appl Physiol. 2023; 123(6):1147-1165.

PMID: 36690907 PMC: 10191996. DOI: 10.1007/s00421-023-05135-1.


References
1.
Borg M, Sherwin R, Borg W, Tamborlane W, Shulman G . Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest. 1997; 99(2):361-5. PMC: 507804. DOI: 10.1172/JCI119165. View

2.
Ganong W . Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol. 2000; 27(5-6):422-7. DOI: 10.1046/j.1440-1681.2000.03259.x. View

3.
Chan O, Zhu W, Ding Y, McCrimmon R, Sherwin R . Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes. 2006; 55(4):1080-7. DOI: 10.2337/diabetes.55.04.06.db05-0958. View

4.
Van Houten M, Posner B, Kopriwa B, Brawer J . Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science. 1980; 207(4435):1081-3. DOI: 10.1126/science.6986652. View

5.
Abdul-Ghani M, DeFronzo R . Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. J Clin Endocrinol Metab. 2007; 92(5):1778-84. DOI: 10.1210/jc.2006-1515. View